稀有がんにおける個人中心の臨床および研究ナビゲーションの実施:カナダの胆管がん共同研究 (C3)
Samar Attieh1,2, Leonard Angka2, Christine Lafontaine2
1Department of Surgery, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Current oncology (Toronto, Ont.)
|August 27, 2025
まとめ
パーソン・センタード・ナビゲーション (PCN) は,まれながん患者の間に 適切な検診,治療,心理的支援を提供することで 支援します. カナダの胆管がん共同研究 (C3) は,胆管がん (BTC) の仮想PCNモデルを使用しています.
科学分野:
- 腫瘍学
- 医療 ナビゲーション
- 患者支援システム
背景:
- パーソン・センタード・ナビゲーション (PCN) は,医療を通して患者を導くための共同アプローチです.
- PCNは,不確実性,限られたサポート,アクセス困難などの課題のために,希少な癌に不可欠です.
- 胆管がん (BTC) は,特殊なナビゲーションを必要とする珍しい癌のグループを表します.
研究 の 目的:
- 胆管がん (BTC) のための仮想人中心ナビゲーション (PCN) モデルを実装し,評価する.
- 情報,検査,心理社会的支援へのアクセスを含む,まれながん患者さんが直面するユニークな課題に取り組むこと.
- 患者の臨床試験,分子検査,専門家のコンサルティングへのアクセスを容易にする.
主な方法:
- カナディアン・コレランジオカルシノマ・コラボレーション (C3) は仮想PCNモデルを使用しています.
- 専用の"C3 研究ナビゲーター"は,個別化された指導,サポートを提供し,サービスへのアクセスを容易にします.
- 実施戦略には,共同設計,適時なサポートの提供,BTCの専門家による全国ネットワークの活用が含まれています.
主要な成果:
- C3仮想PCNモデルは,分子検査,臨床試験,多学科症例レビューへのアクセスを容易にする.
- 全国のBTC専門家のネットワークと患者調査のレジストリを設立した.
- BTC患者コミュニティを支援するアドボカシー活動を開始しました.
結論:
- C3が実装した仮想PCNモデルは,特にBTCの治療における課題を効果的に解決しています.
- 将来の優先事項は,ネットワークの拡張,ユーザーのエンゲージメントの強化,および日常的な臨床実践への統合です.
- PCNは,まれな癌の管理における患者体験の改善に不可欠な要素です.
関連する概念動画
Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


